Artrya (ASX:AYA) Marketable Securities: A$30.15 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:AYA Artrya Ltd ASX:AYA
29 GF Score
Price A$5.36
View Full Analysis

What is Artrya Marketable Securities?

Artrya ASX:AYA -2.72% 29 Marketable Securities is A$30.15 Mil as of Dec. 2025. GuruFocus rates ASX:AYA with a GF Score™ of 29/100.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Artrya's Marketable Securities for the quarter that ended in Dec. 2025 was A$30.15 Mil.

Artrya's annual Marketable Securities declined from Jun. 2023 (A$0.27 Mil) to Jun. 2024 (A$0.15 Mil) but then stayed the same from Jun. 2024 (A$0.15 Mil) to Jun. 2025 (A$0.15 Mil).

Artrya  (ASX:AYA) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Artrya Marketable Securities Related Terms

Artrya Marketable Securities Historical Data

* Premium members only.

The historical data trend for Artrya's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Artrya Marketable Securities Chart

Artrya Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Marketable Securities
0.00 20.27 0.27 0.15 0.15

Artrya Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 0.15 0.15 0.15 30.15
ASX:AYA
29GF Score
Artrya Ltd ASX:AYA
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Artrya Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of A$30.15 Mil mean?
Artrya (ASX:AYA) has a Marketable Securities of A$30.15 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Artrya and its competitors.
Is Artrya's Marketable Securities too high?
Artrya's current Marketable Securities is A$30.15 Mil. Overall, Artrya has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Artrya's Marketable Securities compare to VEEV and BTSG?
Artrya's Marketable Securities of A$30.15 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Artrya and its competitors. Artrya's current Marketable Securities is A$30.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artrya stock overvalued right now?
Artrya (ASX:AYA) has a current Marketable Securities of A$30.15 Mil. The current Marketable Securities is A$30.15 Mil. Artrya's overall GF Score™ is 29/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Artrya (ASX:AYA), the current Marketable Securities is A$30.15 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Artrya Business Description

Address 1257 Hay Street, West Perth, Perth, WA, AUS, 6005
Artrya Ltd is a medical technology company. The company is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. It is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.
29GF Score

Get the complete analysis for ASX:AYA

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$5.36
Price